Managing Toxicities of Novel Therapies and Coordinating Care for CLL/SLL and FL Patients
Expert hematologists/oncologists and a passionate patient advocate discuss ways to improve outcomes in the relapsed/refractory setting of chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and follicular lymphoma (FL). Considerations for collaborative treatment decision-making between oncology teams and their patients will be shared. This archived webinar, conducted in partnership with the Leukemia & Lymphoma Society (LLS) and The CLL Society, illustrates real-world patient survey data collected by PRIME to support patient-centered care approaches.
Related posts